- Home
- CHE vs RGEN Comparison
CHE vs RGEN Comparison
Compare CHE & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHE
- RGEN
- Stock Information
- Founded
- CHE 1970
- RGEN 1981
- Country
- CHE United States
- RGEN United States
- Employees
- CHE N/A
- RGEN N/A
- Industry
- CHE Medical/Nursing Services
- RGEN Medical/Dental Instruments
- Sector
- CHE Health Care
- RGEN Health Care
- Exchange
- CHE Nasdaq
- RGEN Nasdaq
- Market Cap
- CHE 6.4B
- RGEN 6.5B
- IPO Year
- CHE N/A
- RGEN N/A
- Fundamental
- Price
- CHE $438.12
- RGEN $145.02
- Analyst Decision
- CHE Strong Buy
- RGEN Buy
- Analyst Count
- CHE 4
- RGEN 11
- Target Price
- CHE $578.50
- RGEN $170.90
- AVG Volume (30 Days)
- CHE 196.7K
- RGEN 1.1M
- Earning Date
- CHE 10-28-2025
- RGEN 10-28-2025
- Dividend Yield
- CHE 0.54%
- RGEN N/A
- EPS Growth
- CHE N/A
- RGEN N/A
- EPS
- CHE 18.95
- RGEN 0.03
- Revenue
- CHE $2,530,634,000.00
- RGEN $707,890,000.00
- Revenue This Year
- CHE $5.91
- RGEN $16.79
- Revenue Next Year
- CHE $6.72
- RGEN $13.58
- P/E Ratio
- CHE $23.17
- RGEN $4,765.07
- Revenue Growth
- CHE 6.45
- RGEN 11.74
- 52 Week Low
- CHE $408.42
- RGEN $102.97
- 52 Week High
- CHE $623.61
- RGEN $182.52
- Technical
- Relative Strength Index (RSI)
- CHE 49.10
- RGEN 47.85
- Support Level
- CHE $423.05
- RGEN $144.18
- Resistance Level
- CHE $450.00
- RGEN $151.25
- Average True Range (ATR)
- CHE 14.73
- RGEN 6.72
- MACD
- CHE 0.57
- RGEN -2.33
- Stochastic Oscillator
- CHE 29.37
- RGEN 5.75
About CHE Chemed Corp
Chemed Corp purchases, operates, and divests subsidiaries engaged in diverse business activities to maximize shareholder value. Through its subsidiaries, the company operates in the following segments: VITAS and Roto-Rooter. The VITAS segment generates the majority of the firm's revenue and provides hospice and palliative care services to patients with terminal illnesses through a network of physicians, registered nurses, home health aides, social workers, and volunteers. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration, and related services to residential and commercial customers.
About RGEN Repligen Corporation
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.